OPTIZORB Trademark

Trademark Overview

On Friday, April 12, 2019, a trademark application was filed for OPTIZORB with the United States Patent and Trademark Office. The USPTO has given the OPTIZORB trademark a serial number of 88383413. The federal status of this trademark filing is REGISTERED as of Tuesday, October 29, 2019. This trademark is owned by GlaxoSmithKline Consumer Healthcare (UK) IP Limited. The OPTIZORB trademark is filed in the Pharmaceutical Products category with the following description:

Analgesics; anti-inflammatory and antipyretic preparations
optizorb

General Information

Serial Number88383413
Word MarkOPTIZORB
Filing DateFriday, April 12, 2019
Status700 - REGISTERED
Status DateTuesday, October 29, 2019
Registration Number5895619
Registration DateTuesday, October 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Goods and ServicesAnalgesics; anti-inflammatory and antipyretic preparations
Pseudo MarkOPTI ZORB; OPTIMUM ABSORB; OPTIMAL ABSORB

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHALEON UK IP LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWEYBRIDGE, SURREY KT13 0NY
Party NameGlaxoSmithKline Consumer Healthcare (UK) IP Limited
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxoSmithKline Consumer Healthcare (UK) IP Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBrentford, Middlesex TW89GS
Party NameGlaxoSmithKline Consumer Healthcare (UK) IP Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 25, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 13, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 13, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, April 13, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 13, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 13, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, August 28, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 28, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 28, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 28, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 11, 2019ASSIGNED TO LIE
Friday, June 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 24, 2019EXAMINER'S AMENDMENT ENTERED
Monday, June 24, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 24, 2019EXAMINERS AMENDMENT E-MAILED
Monday, June 24, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, June 20, 2019ASSIGNED TO EXAMINER
Tuesday, April 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 16, 2019NEW APPLICATION ENTERED

Related Keywords

optizorb preparations antipyretic inflammatory anti analgesics